Axial spondylitis: Ankylosing spondylitis
Enbrel® is approved across 6 indications, including paediatric indications.¹
An elderly-onset RA patient
A young RA patient worried about treatments that lose effectiveness over time
AS, ankylosing spondylitis; ASAS, Assessment of SpondyloArthritis international Society; axSpA, axial spondyloarthritis; CRP,
C-reactive protein; MRI, magnetic resonance imaging; NSAID, nonsteroidal anti-inflammatory drug; TNF, tumour necrosis factor.
Please click the Prescribing Information link to view the safety and adverse events information of Enbrel®.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
PP-ENB-IND-0814 August 2022
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered Medical Practitioner*, please visit
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.
PP-UNP-IND-0012 July 2022